• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, February 15, 2019

Article

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study published in The American Journal of Managed Care® (AJMC®) was cited by RevCycle Intelligence. The researchers of the study, “Patients’ Views on Price Shopping and Price Transparency,” interviewed patients with access to a price transparency website and found that despite having a positive opinion of price shopping in theory, patients reported barriers to doing so in reality.

The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included 2 articles from AJMC® on curative therapies from the “Paying for Cures: Ensuring patient access and system sustainability” event. The article “Preparing Patients and the Health System for Curative Therapies in the Pipeline” covered a session where experts discussed how the healthcare system can pay for curative therapies that have high upfront costs with benefits that accrue over time. The article “Examining New Payment Ideas for Curative Therapies” sought to answer the question of how the health system can ensure that cutting-edge gene therapies and other curative therapies get to the patients that need them without leaving payers financially exposed.

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.